Macrophage polarisation: An immunohistochemical approach for identifying M1 and M2 macrophages

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Barros, Mário Henrique M ^a   Hauck, Franziska ^b   Dreyer, Johannes H ^a   Kempkes, Bettina ^c   Niedobitek, Gerald ^a  

^a Institute for Pathology   (Germany)

^b SANA KLINIKUM OFFENBACH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD163 ANTIGEN; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; LEUKOCYTE ANTIGEN; MAF PROTEIN, HUMAN; RBPJ PROTEIN, HUMAN; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR C MAF;

CLASSIFICATION; CLUSTER ANALYSIS; CROHN DISEASE; ENTEROBIASIS; FOREIGN BODY GRANULOMA; GENE EXPRESSION; GENETICS; HUMAN; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOPHENOTYPING; MACROPHAGE; METABOLISM; MONONUCLEOSIS; NOSE POLYP; PATHOLOGY; WOUND HEALING;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; CLUSTER ANALYSIS; CROHN DISEASE; GENE EXPRESSION; GRANULOMA, FOREIGN-BODY; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFECTIOUS MONONUCLEOSIS; MACROPHAGES; NASAL POLYPS; OXYURIASIS; PROTO-ONCOGENE PROTEINS C-MAF; RECEPTORS, CELL SURFACE; STAT1 TRANSCRIPTION FACTOR; WOUND HEALING;

EID: 84893863200     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080908     Document Type: Article

References (43)

1. Wynn TA, Barron L (2010) Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 30: 245-257. doi:10.1055/s-0030-1255354. PubMed: 20665377.
2. Mantovani A, Sica A (2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22: 231-237. doi:10.1016/j.coi.2010.01.009. PubMed: 20144856.
3. Gordon S, Martinez FO (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604. doi:10.1016/j.immuni.2010.05.007. PubMed: 20510870.
4. Janeway C (2005) Immunobiology : the immune system in health and disease. xxiii. New York: Garland Publishing House Science. 823 pp.
5. Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122: 787-795. doi:10.1172/JCI59643. PubMed: 22378047.
6. Buechler C, Ritter M, Orsó E, Langmann T, Klucken J et al. (2000) Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 67: 97-103. PubMed: 10648003. (Pubitemid 30046823)
7. Högger P, Dreier J, Droste A, Buck F, Sorg C (1998) Identification of the integral membrane protein RM3/1 on human monocytes as a glucocorticoid-inducible member of the scavenger receptor cysteine-rich family (CD163). J Immunol 161: 1883-1890. PubMed: 9712057. (Pubitemid 28387610)
8. Sulahian TH, Högger P, Wahner AE, Wardwell K, Goulding NJ et al. (2000) Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 12: 1312-1321. doi:10.1006/cyto.2000.0720. PubMed: 10975989.
9. Kamper P, Bendix K, Hamilton-Dutoit S, Honoré B, Nyengaard JR et al. (2011) Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma. Haematologica 96: 269-276. doi:10.3324/haematol.2010.031542. PubMed: 21071500.
10. Zaki MA, Wada N, Ikeda J, Shibayama H, Hashimoto K et al. (2011) Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Virchows Arch 459: 361-366. doi:10.1007/s00428-011-1140-8. PubMed: 21874508.
11. Ino Y, Yamazaki-Itoh R, Shimada K, Iwasaki M, Kosuge T et al. (2013) Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer 108: 914-923. doi:10.1038/bjc.2013.32. PubMed: 23385730.
12. Herrera M, Herrera A, Domínguez G, Silva J, García V et al. (2013) Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients. Cancer Sci 104: 437-444. doi:10.1111/cas.12096. PubMed: 23298232.
13. Lan C, Huang X, Lin S, Huang H, Cai Q et al. (2012) Expression of M2-Polarized Macrophages is Associated with Poor Prognosis for Advanced Epithelial Ovarian Cancer. Technol Cancer Res Treat, 12: 259-67. PubMed: 23289476.
14. Edin S, Wikberg ML, Dahlin AM, Rutegård J, Oberg A et al. (2012) The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLOS ONE 7: e47045. doi:10.1371/journal.pone.0047045. PubMed: 23077543.
15. Barros MH, Hassan R, Niedobitek G (2012) Tumor-associated macrophages in pediatric classical hodgkin lymphoma: association with epstein-barr virus, lymphocyte subsets, and prognostic impact. Clin Cancer Res 18: 3762-3771. doi:10.1158/1078-0432.CCR-12-0129. PubMed: 22645050.
16. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M (2013) Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 229: 176-185. doi:10.1002/path.4133. PubMed: 23096265.
17. Katze MG, He Y, Gale M Jr. (2002) Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2: 675-687. doi:10.1038/nri888. PubMed: 12209136. (Pubitemid 37328725)
18. Cao S, Liu J, Song L, Ma X (2005) The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J Immunol 174: 3484-3492. PubMed: 15749884. (Pubitemid 40354056)
19. Pettersen JS, Fuentes-Duculan J, Suárez-Fariñas M, Pierson KC, Pitts-Kiefer A et al. (2011) Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. J Invest Dermatol 131: 1322-1330. doi:10.1038/jid.2011.9. PubMed: 21307877.
20. Hardison SE, Herrera G, Young ML, Hole CR, Wozniak KL et al. (2012) Protective Immunity against Pulmonary Cryptococcosis Is Associated with STAT1-Mediated Classical Macrophage Activation. J Immunol 189: 4060-4068. doi:10.4049/jimmunol.1103455. PubMed: 22984078.
21. Wang YC, He F, Feng F, Liu XW, Dong GY et al. (2010) Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer Res 70: 4840-4849. doi:10.1158/0008-5472.CAN-10-0269. PubMed: 20501839.
22. Xu H, Zhu J, Smith S, Foldi J, Zhao B et al. (2012) Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nat Immunol 13: 642-650. doi:10.1038/ni.2304. PubMed: 22610140.
23. Crawford DH (2001) Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356: 461-473. doi:10.1098/rstb.2000. 0783. PubMed: 11313005.
24. Verbeke CS, Wenthe U, Bergler WF, Zentgraf H (2000) Characterization of the expanded T cell population in infectious mononucleosis: apoptosis, expression of apoptosis-related genes, and Epstein-Barr virus (EBV) status. Clin Exp Immunol 120: 294-300. doi:10.1046/j.1365-2249.2000.01181.x. PubMed: 10792379. (Pubitemid 30304225)
25. Noël W, Raes G, Hassanzadeh Ghassabeh G, De Baetselier P, Beschin A (2004) Alternatively activated macrophages during parasite infections. Trends Parasitol 20: 126-133. doi:10.1016/j.pt.2004.01.004. PubMed: 15036034.
26. Lucas T, Waisman A, Ranjan R, Roes J, Krieg T et al. (2010) Differential roles of macrophages in diverse phases of skin repair. J Immunol 184: 3964-3977. doi:10.4049/jimmunol.0903356. PubMed: 20176743.
27. Deonarine K, Panelli MC, Stashower ME, Jin P, Smith K et al. (2007) Gene expression profiling of cutaneous wound healing. J Transl Med 5: 11. doi:10.1186/1479-5876-5-11. PubMed: 17313672.
28. Warren KS (1976) A functional classification of granulomatous inflammation. Ann N Y Acad Sci 278: 7-18. doi:10.1111/j.1749-6632.1976.tb47011. x. PubMed: 786128.
29. Maier S, Santak M, Mantik A, Grabusic K, Kremmer E et al. (2005) A somatic knockout of CBF1 in a human B-cell line reveals that induction of CD21 and CCR7 by EBNA-2 is strictly CBF1 dependent and that downregulation of immunoglobulin M is partially CBF1 independent. J Virol 79: 8784-8792. doi:10.1128/JVI.79.14.8784-8792.2005. PubMed: 15994772. (Pubitemid 40934789)
30. Walter SD, Eliasziw M, Donner A (1998) Sample size and optimal designs for reliability studies. Stat Med 17: 101-110. doi:10.1002/(SICI)1097- 0258(19980115)17:1. PubMed: 9463853.
31. Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86: 420-428. doi:10.1037/0033-2909.86.2.420. PubMed: 18839484.
32. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33: 159-174. doi:10.2307/2529310. PubMed: 843571. (Pubitemid 8054849)
33. Chaplin DD (2010) Overview of the immune response. J Allergy Clin Immunol 125: S3-23. doi:10.1016/S0091-6749(10)00745-1. PubMed: 20176265.
34. Bonilla FA, Oettgen HC (2010) Adaptive immunity. J Allergy Clin Immunol 125: S33-S40. doi:10.1016/j.jaci.2009.09.017. PubMed: 20061006.
35. Kato H, Sakai T, Tamura K, Minoguchi S, Shirayoshi Y et al. (1996) Functional conservation of mouse Notch receptor family members. FEBS Lett 395: 221-224. doi:10.1016/0014-5793(96)01046-0. PubMed: 8898100. (Pubitemid 26356190)
36. Heusinkveld M, van der Burg SH (2011) Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med 9: 216. doi:10.1186/1479-5876-9-216. PubMed: 22176642.
37. Waidmann O, Köberle V, Bettinger D, Trojan J, Zeuzem S et al. (2013) Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma. J Hepatol, 59: 769-79. PubMed: 23792028.
38. Reinartz S, Schumann T, Finkernagel F, Wortmann A, Jansen JM et al. (2013) Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse. Int J Cancer, 134: 32-42. PubMed: 23784932.
39. de Vos van Steenwijk PJ, Ramwadhdoebe TH, Goedemans R, Doorduijn EM, van Ham JJ et al. (2013) Tumor-infiltrating CD14-positive myeloid cells and CD8-positive T-cells prolong survival in patients with cervical carcinoma. Int J Cancer, 133: 2884-94. PubMed: 23740735.
40. Vakkila J, Lotze MT, Riga C, Jaffe R (2005) A basis for distinguishing cultured dendritic cells and macrophages in cytospins and fixed sections. Pediatr Dev Pathol 8: 43-51. doi:10.1007/s10024-004-5045-2. PubMed: 15717117. (Pubitemid 40568919)
41. Lau SK, Chu PG, Weiss LM (2004) CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol 122: 794-801. doi:10.1309/QHD6YFN81KQXUUH6. PubMed: 15491976. (Pubitemid 39434761)
42. Nguyen TT, Schwartz EJ, West RB, Warnke RA, Arber DA et al. (2005) Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am J Surg Pathol 29: 617-624. doi:10.1097/01.pas. 0000157940.80538.ec. PubMed: 15832085. (Pubitemid 40577871)
43. Medrek C, Pontén F, Jirström K, Leandersson K (2012) The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 12: 306. doi:10.1186/1471-2407-12-306. PubMed: 22824040.